Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.850
+0.050 (2.78%)
At close: Dec 20, 2024, 4:00 PM
1.890
+0.040 (2.16%)
After-hours: Dec 20, 2024, 4:27 PM EST
Acumen Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
52
Market Cap
111.15M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | 1.44M | -261.00K | -15.38% |
Dec 31, 2019 | 1.70M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionABOS News
- 25 days ago - Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference - GlobeNewsWire
- 5 weeks ago - Acumen Pharmaceuticals, Inc. (ABOS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer's Disease at the 17th Annual Clinical Trials on Alzheimer's Disease Conference - GlobeNewsWire
- 2 months ago - Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference - GlobeNewsWire
- 2 months ago - Lucy Therapeutics Appoints Kim Drapkin as Board Chair - Business Wire
- 2 months ago - Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference - GlobeNewsWire